Moreover, it reduced phospho-BAD expression, exhibited no treatment toxicity and reduced tumor volume.49,50 This pattern of selectivity is often replicated by other PIM inhibitors, as many of them inhibit PIM2 much less efficiently than other PIM kinases.51 The gene discussed is BAD; the disease is neoplasm.